Nexentis Says MitoCareX Completes Initial AI Screening Milestone
Nexentis said MitoCareX completed an initial computational screening milestone using Boltz. The company described the findings as preliminary and not yet experimentally validated.
Related stories
Georgia Banking Co. Shares Trade at $40.15 After Opening at $60
Shares traded at $40.15 after opening at $60 in the company's Nasdaq debut via direct listing. Its prospectus said stockholders would sell up to 7.07 million shares.
M impact | EQUITY | Oct 29, 2026, 07:24 PM UTC
Medical Properties Trust Reports Quarterly Results
Medical Properties Trust reported results for the quarter ended September 30.
M impact | EQUITY | Oct 29, 2026, 07:24 PM UTC
Volkswagen Avoids Puebla Plant Strike With 8.24% Employee Raise
Volkswagen will give employees at its Puebla plant an 8.24% raise this year, averting a strike.
M impact | EQUITY | Oct 29, 2026, 07:23 PM UTC
Federal Signal Reports Q3 2026 Revenue of $655.5M, EPS of $1.29
Third-quarter net income was $79.6 million. Revenue rose 18.1%, net income 16.9% and diluted EPS 16.2% from the prior-year quarter.
M impact | EQUITY | Oct 29, 2026, 07:21 PM UTC
Peoples Bancorp Reports Third-Quarter 2026 Revenue of $119.5 Million
Revenue rose 3.8% year over year to $119.5 million. Net income increased 10.6% to $32.6 million, while diluted EPS rose to $0.91 from $0.83.
M impact | EQUITY | Oct 29, 2026, 07:21 PM UTC
Axalta Reports Third-Quarter 2026 Revenue of $1.31 Billion
Revenue rose 1.8% year over year to $1.31 billion, while net income declined 13.6% to $95 million and diluted EPS fell 13.7% to $0.44.
M impact | EQUITY | Oct 29, 2026, 07:21 PM UTC